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Section B 
Short Answer Questions: 11 
Total No of Marks for this Section:  75 
 
This section should be answered in the Answer Book provided. 
 
 






Sulfanilamide (C6H8 N2O2S) is an antibacterial drug. Its logP value is -0.72.  
  
   
 
 
(a) Redraw the structure in your answer paper and label all the possible binding interactions that can 
take place in the binding site between Sulfanilamide molecule and the amino acid residues of 
theprotein involved.   
[3 marks] 
 
(b) Calculate the other properties of sulfanilamide relating to ‘Lipinski-Rule of Five’. State whether the 
molecule is drugable and explain your answer.    [Atomic weight of H= 1.01 g/mol, C=12.01 g/mol, N 
=14.01 g/mol, O =16 g/mol, F =19.00 and S= 32.07] 
 
 [4 marks] 
  
 Semester 2, 2018 FINAL EXAMINATION Page 22 of 30  
PHA214 – Biotechnology and Pharmacogenomics 
 
THIS EXAMINATION PAPER AND SUPPLIED MATERIALS ARE NOT PERMITTED TO BE REMOVED FROM ANY EXAMINATION VENUE IN ANY 




(a) The graphs below represents a plot of %concentration versus pH and logD versus pH of 
sulfanilamide. sulfanilamide’s pKa values are  2.27 and 10.99.  With reference to the graphs, discuss 
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(b) The following figure gives the free-energy landscape diagram of protein folding for villin. The 
landscape consists of five states: denatured basin (D), first transition state (TS1), intermediate state 
(I), second transition state (TS2), and native basin (N). Discuss the significance of different states of 
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Log P of benzoic acid is 1.89. Using the data provided in the table below, for substituents of benzoic 




(a) Calculate the logP value for  




(b) Which of the above 3 compounds will be most hydrophobic? Explain your answer.  
 [2 marks] 
 
 
(c) What position of the benzoic acid would you add the -OH group to make the acid stronger?  Sketch 
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(a) Thiopurine agents, such as azathiopurine (AZA). Are widely used for the treatment of acute 
leukaemias, inflammatory bowel diseases and other immunological disorders. AZA is a pro-drug that 
is rapidly converted to its active metabolites, such as 6-mercaptopurine, 6-thioinosine 
monophosphate and 6-TGN. Reduced enzymatic activity is associated with increased 6-TGn levels, 
which may result in direct incorporation of 6-TGN into DNA and cause cytotoxic and 
immunosuppression. 
 
Using the below table, discuss the data in terms of genotype and drug metabolism. 
Factors 
TMPT wild type 
(n = 143) 
TMPT heterozygous 
(n = 6) 
Total  
(n = 149) 
Demographics    
 Age (yr) 48.6±13.1 48.5±19.5 48.6±13.2 
 Sex    
  Male  47 3 50 
  Female 96 3 99 
 Disease    
  Behçet disease 111 5 116 
  Atopic dermatitis 10 0 10 
  Lichen planus 4 0 4 




3 0 3 
  Dermatomyositis 2 0 2 
  Psoriasis vulgaris 2 0 2 
  Chronic urticaria 2 0 2 
  Others 6 0 6 
Administration of AZA    
 Number of patients 119 4 123 
 Dosage (mg/d) 62.02 ± 22.68 43.75 ± 12.50 61.42 ± 22.72 
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Explain the role of Phase I, Phase II and Phase III proteins in drug metabolism. 
(Marks: 3) 
 
Although the phases do not have to be sequential in order, they make sense as a progression from 







Paracetamol is normally metabolised via conjugation, but has the potential to undergo oxidative 
metabolism. Explain the inhibition and induction of both the primary and alternative pathways, 
concentrating on the interaction of paracetamol metabolism with that of ethanol, and explain how 
incorrect consumption of paracetamol can lead to fatal hepatotoxicity. 
(8 marks) 
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Restriction enzymes are an important tool, with each DNA sequence being unique, producing 
specific fragment sizes.  
 
(a) Imagine the DNA strand shown in Figure 1 was cut with EcoR1 and placed in lane C (Figure 2). 
Draw the band in lane C as they would appear after electrophoresis, and indicate the size of 
each of the DNA fragments in base pairs. 
 




Figure 2: Agrose gel containing DNA fragments separated by electrophoresis. 
 
(b) Explain the process of electrophoresis and how it is used to separate DNA fragments. 
 (Marks: 9) 
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A group of 20 recurrence breast cancer patients (taking tamoxifen) were selected for a study, 
regarding tamoxifen treatment. 19 aged matched women who had already completed 5 years of 
tamoxifen treatment with no recurrence, were used as controls. (Table 1). Genomic DNA was collected 
and amplified by PCR to determine if SNPs could influence the efficiency of tamoxifen treatment (Table 
2). 
  
Characteristic Case group 
(n = 20) 
Control group  
(n = 19) 











































Table 1: Patient characteristics 
 
SNP Allele Frequencies 
Case group 
(n = 20) 
Control group  
(n = 19) 
CYP2D6*10 
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(a) Using the above data, which of the following SNPs most likely plays a role in tamoxifen 
treatment? 
 (Marks: 2) 
 
(b) Using your understanding of drug metabolism, explain why the patients displaying the variant 
genotype had a shorter disease free survival than the matched controls. 






DNA fragments for two genes (Bt resistance and GFP) were generated through PCR with the addition 
of restriction enzymes (HindIII) at the 5’- and 3’-ends. The DNA fragments were inserted into a plasmid 
and transformed into plants so that they were resistant to certain insects (Bt gene) as well as fluoresce 
(GFP gene). 
 
(a) List the reagents that are necessary for a reaction to occur and explain the role of each reagent. 
(Marks: 4) 
 




(c) Would it have been possible for the plant to be transformed with the Bt gene and not the GFP 
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Paul is a 25-year-old schizophrenic who has successfully been treated with clopine for over 12 months. 
Clopine is metabolised by CYP1A2. With the support and encouragement of his family and friends, he 
recently started a new job. He regularly smoked two packets of cigarettes a day, but the new job has 
kept him busy and he now only has a couple of cigarettes a day. During the next couple of weeks, Paul 
increasingly feels lethargic and fatigued. He assumed this was due to his new job, so started having 
several cups of coffee (caffeine is a substrate for CYP1A2) a day to try to help ‘perk’ him up. However, 
he further deteriorated developed muscle spasms, dizziness, blurred vision and confusion. 
a) Explain how the sudden decrease in smoking had effected Paul.   





A new drug has been developing to treat prostate cancer. This drug is designed to be taken orally every 
day during the treatment period, and it inhibits the growth of the cancer cell. During the initial clinical 
trial, it is found that 20% of the studies population has a very low blood concentration of the drug. 
Briefly outline THREE (3) possible mechanism of genetic variation that can explain this observation. 
   
(Marks: 3) 
 
